<SEC-DOCUMENT>0001564590-16-020170-index.html : 20160531
<SEC-HEADER>0001564590-16-020170.hdr.sgml : 20160531
<ACCEPTANCE-DATETIME>20160531163132
ACCESSION NUMBER:		0001564590-16-020170
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		11
CONFORMED PERIOD OF REPORT:	20160627
FILED AS OF DATE:		20160531
DATE AS OF CHANGE:		20160531
EFFECTIVENESS DATE:		20160531

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sarepta Therapeutics, Inc.
		CENTRAL INDEX KEY:			0000873303
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				930797222
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14895
		FILM NUMBER:		161686282

	BUSINESS ADDRESS:	
		STREET 1:		215 FIRST STREET
		STREET 2:		SUITE 415
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		617-274-4000

	MAIL ADDRESS:	
		STREET 1:		215 FIRST STREET
		STREET 2:		SUITE 415
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Sarepta Therapuetics, Inc.
		DATE OF NAME CHANGE:	20120712

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AVI BIOPHARMA INC
		DATE OF NAME CHANGE:	19980930

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANTIVIRALS INC
		DATE OF NAME CHANGE:	19970123
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>srpt-def14a_20160627.htm
<DESCRIPTION>DEF 14A
<TEXT>
Document 1 - file: srpt-def14a_20160627.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>gucfgrsy2pgu000007.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 2 - file: gucfgrsy2pgu000007.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>gucfgrsy2pgu000006.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: gucfgrsy2pgu000006.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>gucfgrsy2pgu000001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: gucfgrsy2pgu000001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>gucfgrsy2pgu000008.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: gucfgrsy2pgu000008.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>gucfgrsy2pgu000009.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: gucfgrsy2pgu000009.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>gucfgrsy2pgu000010.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 7 - file: gucfgrsy2pgu000010.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>8 <FILENAME>gucfgrsy2pgu000002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 8 - file: gucfgrsy2pgu000002.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>9 <FILENAME>gucfgrsy2pgu000003.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 9 - file: gucfgrsy2pgu000003.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>10 <FILENAME>gucfgrsy2pgu000004.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 10 - file: gucfgrsy2pgu000004.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>11 <FILENAME>gucfgrsy2pgu000005.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 11 - file: gucfgrsy2pgu000005.jpg
</DOCUMENT> </SEC-DOCUMENT>